Aligos Share Price

Aligos Share Price

NASDAQ: ALGS | Micro Cap | Healthcare
$1.30
-$0.07 (-5.43%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Aligos Stock Performance

Open
$1.40
Prev. Close
$1.38
Circuit Range
N/A
Day Range
$1.32 - $1.51
Year Range
$1.32 - $13.58
Volume
2,469
Average Traded
$1.39

Aligos Share Price Today

As of 19 November 2026, Aligos Therapeutics, Inc.'s share price is $1.30. The stock opened at $1.40, compared to its previous close of $1.38. During today's trading session, Aligos Therapeutics, Inc.'s share price traded between $1.32 and $1.51, with an average price of $1.42. Over the past 52 weeks, the stock has recorded a high of $13.58 and a low of $1.32. In terms of performance, Aligos Therapeutics, Inc.'s share price has declined by 77.19% over the last six months and is down 86.53% on a year-on-year basis.

Aligos Share Price Chart

Line chart of the Aligos price trend over the selected period. The price fell overall, ranging from 1.30 to 1.51, ending at 1.30.
$1.32$1.51
L
Show Current Price
H

Aligos Stock Fundamentals & Key Indicators

Market Cap
$12.90M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.61
Revenue (TTM)
$2.19B
Return On Equity (TTM)
-586.28%
Profit Margin
-1104.57%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-9.96%

Aligos Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.17$2.83$27.78$2.87
Net Profit-$19.88-$23.04-$1.50-$21.86
Net Profit Margin-11694.12%-814.13%-5.40%-761.67%
Income ChangeN/A-15.90%93.49%-1357.33%

Aligos Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.91$15.53$3.95$2.19
Net Profit-$96.05-$87.68-$131.21-$24.19
Net Profit Margin-690.51%-564.58%-3321.77%-1104.57%
Income ChangeN/A8.71%-49.65%81.56%

Aligos Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets5.677.9510.4413.15
Current Assets82.8662.14141.08133.55
Total Assets88.5370.09151.53146.69
Non Current Liabilities13.7677.3335.549.66
Current Liabilities21.2321.7423.9133.13
Total Liabilities34.9999.0759.4542.79
Shareholders' Equity53.55-28.9792.08103.9

Aligos Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-82.5-80.74-79.0-79.39
Investing-37.83-18.2844.98-26.29
Financing101.640.3688.330.16

Corporate Actions

Split
Ex-date: 19 Aug 2024

About Aligos

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Aligos Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.73
$1.34
-73.20%
Oct 2026
$5.49
$5.00
-9.42%
Sep 2026
$5.65
$5.52
-21.92%
Aug 2026
$4.21
$7.07
+65.77%
Jul 2026
$5.65
$4.26
-25.63%
Jun 2026
$5.52
$5.74
+0.26%
May 2026
$6.16
$5.72
-5.61%
Apr 2026
$7.84
$6.06
-14.35%
Mar 2026
$6.73
$7.08
+2.09%
Feb 2026
$7.96
$6.93
-14.54%
Jan 2026
$9.21
$8.11
-13.92%
Dec 2025
$9.60
$9.42
-2.79%

Aligos Share Price FAQs